$145.06-2.54% · 3M
Moving avg
1W+8.85%
1M-10.49%
3M-2.54%
6M-42.17%
YTD-48.73%
1Y-53.15%
3Y-35.21%
5Y-48.44%
52-week range
$138.793% of range$354.88
Company health
Value1/6
Growth6/6
Profitability4/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 48% upside to a $214 target
- Analyst consensus is "Buy"
- High return on equity (2138%)
- Revenue compounding 23% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$10.05B
Enterprise value
$11.44B
P/E ratio (TTM)
36.75x
P/S ratio (TTM)
3.78x
EV/EBITDA
19.89x
Per share & returns
EPS (TTM)
$4.33
Dividend yield
0.00%
Beta (1Y)
1.11
30-day change
-10.49%
Trading
Volume (24h)
1.57M
Previous close
$144.70
Shares outstanding
69.26M
About Insulet Corp.
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Symbol
PODD
Insulet Corp. is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NASDAQ (United States) and trade under the ticker PODD.
Frequently asked questions
What is Insulet Corp.'s market cap?
Insulet Corp. (PODD) has a market capitalization of $10.05B.
What is Insulet Corp.'s P/E ratio?
Insulet Corp. trades at a price-to-earnings (P/E) ratio of 36.75.
What exchange does PODD trade on?
PODD trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap